Method of lowering LDL cholesterol in blood
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 24, 1990
Grant Date -
N/A
app pub date -
Dec 28, 1988
filing date -
Dec 28, 1988
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Therapeutic amounts of DHEA are administered to human patients for the treatment and prevention of such disorders as atherosclerosis, angina, diabetes, obesity and congestive heart failure. Administering therapeutic quantities of DHEA to human patients has been found to reduce body fat mass and increase muscle mass, lower serum LDL cholesterol levels, lower serum apoB levels, and not affect tissue sensitivity to insulin.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully